Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNA interference in cancer.

Andrei L Gartel1, Eugene S Kandel

  • 1Department of Medicine, University of Illinois at Chicago, 60612, USA. agartel@uic.edu

Biomolecular Engineering
|February 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers.

Cell death & disease·2026
Same author

Inhibitors of De Novo Guanylate Biosynthesis Enhance the Potency of MAPK Cascade Inhibitors Against Colorectal Cancer.

International journal of molecular sciences·2025
Same author

Inhibition of the RAC/PAK Signaling Axis Enhances the Potency of MAPK Cascade Inhibitors Against Uveal Melanoma.

Biomolecules·2025
Same author

Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies.

Cell death discovery·2024
Same author

Regulation of HOX gene expression in AML.

Blood cancer journal·2024
Same author

Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2024
Same journal

Proceedings of Symposium J on Surface Functionalization of Biomaterials at the E-MRS 2006 Fall Conference. September 4-6, 2006. Warsaw, Poland.

Biomolecular engineering·2008
Same journal

Overexpression of GLT1 in fps1DeltagpdDelta mutant for optimum ethanol formation by Saccharomyces cerevisiae.

Biomolecular engineering·2007
Same journal

Fibrils of different collagen types containing immobilised proteoglycans (PGs) as coatings: characterisation and influence on osteoblast behaviour.

Biomolecular engineering·2007
Same journal

Development of a heat shock inducible and inheritable RNAi system in silkworm.

Biomolecular engineering·2007
Same journal

Effect of site-directed PEGylation of trichosanthin on its biological activity, immunogenicity, and pharmacokinetics.

Biomolecular engineering·2007
Same journal

Real-time study of the effect of different stress factors on lactic acid bacteria by electrochemical optical waveguide lightmode spectroscopy.

Biomolecular engineering·2007
See all related articles

RNA interference (RNAi) is a key gene regulator in eukaryotes. microRNAs are linked to cancer, and short interfering RNAs offer therapeutic potential for cancer gene modulation.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • RNA interference (RNAi) is a significant regulatory mechanism in eukaryotic gene expression.
  • microRNAs (miRNAs) are increasingly recognized for their roles in cancer, acting as tumor suppressors or oncogenes.
  • RNAi has been developed into a powerful tool for artificial gene expression modulation using short interfering RNAs (siRNAs).

Purpose of the Study:

  • To review the evidence linking microRNA involvement to cancer.
  • To explore the application of short interfering RNAs in cancer genetics.
  • To discuss the benefits and limitations of experimental RNAi in cancer research.

Main Methods:

  • Review of scientific literature on RNA interference and microRNAs in cancer.

Related Experiment Videos

  • Analysis of studies utilizing short interfering RNAs for gene modulation in cancer models.
  • Evaluation of experimental data on the efficacy and challenges of RNAi therapeutics.

    • Main Results:

    • Changes in microRNA levels are associated with cancer development, identifying new tumor suppressors and oncogenes.
    • Short interfering RNAs serve as potent tools for both forward and reverse genetics in cancer research.
    • In vitro and in vivo studies demonstrate successful inhibition of tumor cell growth using RNAi targeting oncogenes.

    Conclusions:

    • microRNAs play a crucial role in oncogenesis and tumor suppression.
    • Experimental RNAi offers promising therapeutic strategies for cancer treatment.
    • Further research is needed to optimize RNAi delivery and overcome limitations for clinical application.